Contact this trialFirst, we need to learn more about you.
Device
Combined Infusion System for Hepatic Cancer
Recruiting1 award5 criteria
Philadelphia, Pennsylvania
This trial is for adults with colorectal cancer metastatic to the liver or intrahepatic cholangiocarcinoma who will receive the Medtronic SynchroMed II programmable pump combined with the Intera tapered catheter for hepatic artery infusion (HAI) of a standard chemotherapy (FUDR). The primary objective is to assess the safety of using this pump/catheter combination.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service